Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Biochem Pharmacol. 2012 May 10;84(3):352–365. doi: 10.1016/j.bcp.2012.04.022

Figure 9.

Figure 9

Representative traces illustrating qualitative differences in the mecamylamine inhibition of the zebrafish heteromeric nAChR and effects on subsequent ACh applications. The traces illustrate the effect of 3 µM mecamylamine co-application with ACh at the concentrations indicated. Note that for the α3β4 and muscle-type receptors there was good recovery of ACh control responses, but for α4β2 and α2β2 receptors there was only partial recovery of the control peak currents.